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Purpose: Ceria engineered nanomaterials (ENMs) have current commercial applications and
both neuroprotective and toxic effects. Our hypothesis is that ceria ENMs can associate with
brain capillary cells and/or cross the blood–brain barrier.
Methods: An aqueous dispersion of ∼5 nm ceria ENM was synthesized and characterized in
house. Its uptake space in the Sprague Dawley rat brain was determined using the in situ brain
perfusion technique at 15 and 20 mL/minute flow rates; 30, 100, and 500 µg/mL ceria perfused
for 120 seconds at 20 mL/minute; and 30 µg/mL perfused for 20, 60, and 120 seconds at 20 mL/
minute. The capillary depletion method and light and electron microscopy were used to determine
its capillary cell and brain parenchymal association and localization.
Results: The vascular space was not significantly affected by brain perfusion flow rate or
ENM, demonstrating that this ceria ENM did not influence blood–brain barrier integrity.
Cerium concentrations, determined by inductively coupled plasma mass spectrometry, were
significantly higher in the choroid plexus than in eight brain regions in the 100 and 500 µg/mL
ceria perfusion groups. Ceria uptake into the eight brain regions was similar after 120-second
perfusion of 30, 100, and 500 µg ceria/mL. Ceria uptake space significantly increased in the
eight brain regions and choroid plexus after 60 versus 20 seconds, and it was similar after 60
and 120 seconds. The capillary depletion method showed 99.4% ± 1.1% of the ceria ENM
associated with the capillary fraction. Electron microscopy showed the ceria ENM located on
the endothelial cell luminal surface.
Conclusion: Ceria ENM association with brain capillary endothelial cells saturated between 20
and 60 seconds and ceria ENM brain uptake was not diffusion-mediated. During the 120-second
ceria ENM perfusion, ceria ENM predominately associated with the surface of the brain capillary
cells, providing the opportunity for its cell uptake or redistribution back into circulating blood.
Keywords: ceria engineered nanomaterial, brain microvascular endothelial cell association, in
situ brain perfusion, capillary depletion
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Commercial and scientific interest in ceria engineered nanomaterials (ENMs) has
expanded rapidly in recent years. Numerous studies have found ceria to be neuroprotective, suggesting that it has utility in medical disorders caused by reactive oxygen
species.1–6 In retinal neurons, 5 nm ceria ENM inhibited H2O2-induced reactive oxygen species.7 Ceria ENMs enhanced spinal neuron viability 3 and protected a mixed
culture of cortical neurons and glial cells from H2O2-induced injury.8 A protective
effect of ceria ENMs on mouse hippocampal slices was demonstrated in a model of
ischemia.5 Although these reports showed the therapeutic potential of ceria ENM as a
neuroprotective agent, none has investigated the ability of ceria ENMs to associate with
International Journal of Nanomedicine 2012:7 4023–4036
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and/or cross the blood–brain barrier (BBB). Other studies
have found that ceria ENMs can cause oxidative stress and
induce toxicity.9–11 In light of the potential neuroprotective
therapeutic applications and toxicity concerns of ceria ENMs,
it is very important to understand their interaction with the
BBB and brain parenchyma.
Brain capillary endothelial cells cooperate with pericytes,
astrocytes, and neurons to generate and maintain the unique
barrier properties of the BBB, which plays a crucial role
in safeguarding the brain from endogenous and exogenous
compounds circulating in the blood.12 Although the BBB is a
tightly regulated barrier, ENMs are being extensively investigated as an approach to deliver drugs to the central nervous
system, based on their unique physicochemical properties,
such as tight junction disruption, increased retention at the
brain capillaries combined with adsorption to the capillary
walls, and receptor-mediated transcytosis.13,14 Several studies
have indicated that metal ENMs altered BBB integrity and
increased its permeability, and/or led to toxicity to the BBB
and the brain.15,16 The biodistribution of 15, 50, 100, and
200 nm gold nanoparticles was investigated 24 hours after
its intravenous (IV) administration. The 15 and 50 nm gold
crossed the BBB and entered the brain; the larger ENMs did
not.17 After oral gavage, 25 nm ceria appeared in the brain one
day later and was still present in the brain on day 7.18 Although
these studies indicated that some metal oxide ENMs have
the potential to cross the BBB, most studies on brain ENM
uptake did not separate the capillary endothelial cells from
the brain cells, making it difficult to determine whether the
ENMs entered the brain or if their distribution was limited
to the capillary endothelial cells. More research is needed
in order to understand the distribution of ENMs between
capillary endothelial cells and/or brain tissue.
Our previous findings showed that 5 nm ceria ENM
agglomerates in the brain capillary lumen. Electron microscopy (EM) did not reveal ceria ENM inside microvascular
endothelial or brain cells. Ceria did not produce profound
pro- or antioxidant effects in the brain one or 20 hours after
a 1-hour systematic IV infusion.19 The reasons for the lack
of ceria ENMs in the brain are unknown. One possibility is
that the ceria ENMs were rapidly coated by proteins in the
blood that changed their physicochemical properties, resulting in their rapid clearance by the mononuclear phagocyte
system.20,21 Another possibility is that the nanoparticles
agglomerated very rapidly in the blood or on a biological
surface, changing their distribution and cell interaction,22–25
so that the agglomerated ceria became too large or unavailable
to penetrate the intact BBB. The present study utilized a
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controlled system to better understand how ceria ENMs
interact with brain capillary endothelial cells. The results are
relevant to the therapeutic use and toxicological consideration
of ceria ENMs.
The objective of this study was to investigate the brain
capillary cell association and brain entry rate of a 5 nm
ceria ENM. We used the in situ brain perfusion method to
evaluate BBB integrity and determine brain entry rate at different perfusion flow rates, ceria ENM concentrations, and
perfusion durations. Eight brain regions and a choroid plexus
(ipsilateral to the perfusion) were collected to test regional
differences in BBB integrity and ceria ENM brain entry
rate. The capillary depletion method was used to evaluate
ceria ENM distribution between capillary and brain tissues.
Light microscopy (LM) and EM were used to investigate the
localization of ceria nanoparticles.

Materials and methods
Nanomaterial
The 5 nm ceria ENM was synthesized using a previously
reported method (supplementary materials).19 The physico
chemical properties of the ceria ENMs were determined
in our laboratories. All of the methods have been reported
previously (supplementary material).26 Free cerium in the
ceria ENM dispersion was removed by ultrafiltration, using
3 kDa molecular weight cutoff regenerated cellulose centrifugal filtration devices (Amicon Ultra-4; EMD Millipore,
Billerica, MA). The 5 nm ceria (3.5 mL) was added to
the Amicon Ultra filter unit. The unit was centrifuged at
4800 g for 35 minutes to obtain 3 mL filtrate and 0.5 mL
concentrated ceria ENM. The 3 mL filtrate (containing free
cerium) was removed from the centrifuge tube, and 3 mL
sodium citrate (0.17 M) solution was added to the filtration device to disperse the ceria ENM. After conducting
this washing procedure three times, sodium citrate solution (3 mL; 0.17 M) was added to the filtration device,
which was bath sonicated for 15 minutes to redisperse
the ceria ENM. The Ce concentrations of the 5 nm ceria
ENM dispersion and free cerium in the ultrafiltrate were
analyzed by inductively coupled plasma mass spectrometry
(ICP-MS).19,26

Perfusate for in situ brain perfusion

The perfusate contained 30, 100, or 500 µg/mL ceria ENM
in a solution of Na+ (153 mM), K+ (4.2 mM), Ca2+ (1.5 mM),
Mg2+ (0.9 mM), Cl– (162 mM), and glucose (9 mM). Gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA)
(1 mM) was added to determine BBB integrity. It has been
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shown that Gd-DTPA, a marker for vascular space, does
not significantly cross the intact BBB, due to its charge and
high molecular weight.27 A significant increase of Gd-DTPA
in brain samples indicates BBB damage. Following at least
1-hour incubation at 37°C, the perfusate was bubbled for
2 minutes with 95/5 air/CO2 and adjusted to pH 7.4 prior
to its use.28

Ceria ENM stability in the perfusate
Ceria ENM stability in the perfusate was determined from 1
to 230 minutes (after addition to perfusate) using dynamic
light scattering (90Plus Nanoparticle Size Distribution
Analyzer; Brookhaven Instruments Corp, Holtsville, NY).
The intensity-weighted hydrodynamic diameter in the
perfusate was measured at 1000 µg/mL at 37°C, and then it
was converted to number- and volume-weighted averages.

Animals
In this study, 55 male Sprague Dawley rats were used,
weighing 330 ± 35 g (mean ± standard deviation [SD]).
Prior to the study, the animals were housed individually
in the University of Kentucky Division of Laboratory
Animal Resources Facility. Animal work was approved by
the University of Kentucky Institutional Animal Care and
Use Committee (Protocol 2008-0272). The research was
conducted in accordance with the Guiding Principles in the
Use of Animals in Toxicology.

In situ brain perfusion methods
We employed the modification of the brain perfusion technique as previously reported.28–30 Briefly, the rat was anesthetized under ketamine/xylazine anesthesia (75 and 5 mg/kg),
and its left carotid artery was exposed. Following ligation of
the external carotid, occipital, and common carotid arteries,
PE60 tubing containing heparin (100 U/mL, in 0.9% NaCl)
was inserted into the common carotid. We used the heart-cut
modification of this technique and increased the perfusate
flow rate to 20 mL/minutes.31 The rat was decapitated to end
the perfusion, and the brain was harvested and cleaned of
meninges and surface vessels. Brain tissue (∼20 mg from
each brain region, except the choroid plexus, which averaged 0.9 ± 0.4 mg) was collected from the frontal cortex,
parietal cortex, occipital cortex, thalamus/hypothalamus,
midbrain/colliculus, striatum, cerebellum, hippocampus, and
choroid plexus, from the left hemisphere, for measurement
of Gd-DTPA (as gadolinium) and ceria ENM (as cerium)
by ICP-MS. Cerebrovascular washout of the perfusate was
conducted to test the influence of ceria concentrations in the
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vascular space on the brain uptake space. The cerebrovascular
space was washed at the same perfusion rate (n = 4 rats) for
20 seconds, with ceria-free perfusate, immediately following
100 µg ceria ENM/mL perfusion for 120 seconds at 20 mL/
minute. The results were compared to those obtained without
cerebrovascular washout, using a two-way analysis of variance (ANOVA). The brain uptake space in the washout and
nonwashout conditions did not show a significant difference
after correcting for the vascular volume. Therefore, washouts
were not conducted in the rest of the studies, except for the
capillary depletion experiment, and three rats perfused for
LM and EM examination.
Flow-rate-dependent uptake is a property of some
carrier-mediated uptake systems, but it is not a property of
diffusion.28 Therefore, to examine the effect of perfusion
flow rate on influx rate and the vascular and brain extracellular fluid volumes, 15 and 20 mL/minute flow rates
(100 µg ceria ENM/mL) were tested in four and five rats,
respectively. To determine whether ceria ENM brain entry
is concentration-dependent, three ceria ENM concentrations (30, 100, and 500 µg/mL) were investigated, using a
perfusion rate of 20 mL/minute for 120 seconds (n = 4, 6,
and 5 rats, respectively). Ceria ENM brain entry during the
different perfusion durations was investigated to determine
how fast ceria ENM associates with brain capillary cells or
enters the brain. Perfusion durations of 20, 60, and 120 seconds, using a rate of 20 mL/minutes and 30 µg ceria ENM/mL
were studied in 4 treated animals and 3 control animals in
each group. Three animals were prepared for LM and EM
after perfusion with 100 µg ceria ENM/mL, 20 mL/minute
for 120 seconds, followed by a 20-second washout with
ceria-free perfusate.

Capillary depletion method
The capillary depletion method was used to separate brain
parenchyma from capillary tissue.28,32 After a 30-µg/mL,
120-second, 20-mL/minute ceria ENM perfusion, a 20-second
washout was conducted. The forebrain from the perfused
hemisphere was isolated from 10 rats (2 control and 8
treated), and the lateral ventricle choroid plexus in the perfused hemisphere was removed. The tissue was homogenized
in 3.5 mL physiological buffer containing 141 mM NaCl,
4 mM KCl, 2.8 mM CaCl2, 1 mM NaH2PO4, 1 mM MgSO4,
10 mM glucose, and 10 mM HEPES at pH 7.4. Dextran
(70,000 g/mol) was then added to 18% (w/v), and the sample
was further briefly homogenized. After centrifugation at
5400 x g for 15 minutes at 4 °C, the supernatant (brain-rich
fraction) and pellet (capillary-rich fraction) were carefully
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separated for measurement of ceria ENM by ICP-MS. The
percentage of the forebrain ceria ENM in the capillaryrich fraction = (mass amount of cerium in the capillaryrich fraction/mass amount of cerium in the capillary-rich
fraction + brain-rich fraction) × 100%. The percentage of the
ceria ENM dose in the capillary rich fraction = (mass amount
of cerium in the capillary-rich fraction/mass amount cerium
in the total ceria ENM dose) × 100%.

Cerium and gadolinium analysis
Cerium and gadolinium were analyzed by ICP-MS
(Agilent 7500cx; Agilent Technologies, Santa Clara, CA),
as previously described.16,33 The method detection limits of
Ce and Gd in tissue were 0.013 mg Ce/kg and 0.0004 mg
Gd/kg.

Light and electron microscopy
The rats were decapitated at the end of the in situ washout
perfusion for brain removal. After bisection, each hemisphere was immediately immersed in a fixative containing 2% paraformaldehyde–2% glutaraldehyde in 0.1 M
cacodylate buffer, for 24 hours at 4°C. Tissue samples
from the pituitary gland, hippocampus, and choroid plexus
were identified with the aid of a dissecting microscope and
stored in 0.1 M cacodylate buffer. Samples were cut to
approximately 3 mm3 before being dehydrated in ascending concentrations of ethanol and embedded in Araldite
502 (Electron Microscopy Sciences, Hatfield, PA). After
polymerization, the blocks were sectioned at a thickness of
one micron and toluidine blue-stained for screening, and
selected blocks were sectioned at a thickness of 80 nm for
transmission electron microscopy viewing with a Philips
CM 10 electron microscope, (FEI Company, Hillsboro, OR),
operated at 80 kV.

Data and statistical analysis
The distribution volume, or uptake space (Q), derived from
the in situ brain perfusion results, is the amount of brain tissue
into which the substrate distributes during a given perfusion
duration. Qceria total (mL/g) = ceria ENM in tissue (µg/g)/ceria
per volume of perfusate (µg/mL).34 The mass amount of
ceria ENM per gram of brain (µg/g) was also calculated, in
order to compare the results of perfusion of the three ceria
ENM concentrations. Gd-DTPA uptake space (vascular
plus extracellular space) was used to correct the ceria ENM
brain uptake space results.28 QGd-DTPA = Gd-DTPA in tissue
(μg/g)/ Gd-DTPA per volume of perfusate (µg/mL). Corrected
brain Qceria ENM = Qceria total – QGd-DTPA. The corrected mass
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amount of ceria ENM per gram of brain (µg/g) = (Qceria total –
QGd-DTPA) (mL/g) × ceria per volume of perfusate (µg/mL).
Grubbs’ test was used to determine outliers. Two-way
ANOVA, followed by Bonferroni multiple comparisons, was
used to test for significant differences among the three concentration groups and nine different regions (GraphPad Prism
Version 3.00 for Windows; GraphPad Software, San Diego,
CA). The percentage of the capillary surface area that would
be covered by ceria ENMs was calculated as = (number of
ceria ENM particles in the perfused hemisphere × crosssectional area of a ceria particle) × 100%/rat brain capillary
endothelial cell surface area. This was based on the ceria
average diameter, the ceria density = 7.132 g/cm3, and the
rat’s capillary surface area = 140 cm2/g brain.35 All results
are reported as mean ± SD.

Results
Nanoparticle characterization
The ceria ENM was polyhedral, and the X-ray diffraction
pattern showed the ceria to be highly crystalline. It was
face-centered cubic, with corresponding Miller indices of the
most common faces of (111), (220), and (311). Evaluation
of a number of transmission electron microscopy images
(Figure 1A) showed that Dmean (average primary particle
diameter from number frequency distribution) and standard
deviation based on transmission electron microscopy measurements of diameter fitted using lognormal distribution
models was 4.6 ± 0.1 nm. Dynamic light scattering results
of a representative batch of ceria dispersion showed that 98%
of the particles were in the range of 6.7–8.2 nm (Figure 1B).
Zeta potential was −53 ± 7 mV at pH ∼7.35 in water.
The ceria ENM surface area was 121 m2/g. The extent of
surface citrate coating was ∼40%;19 5% free cerium ions were
in the ceria ENM. After the three filtrations, less than 0.05%
of the ceria ENM perfusate was free cerium ions. Ceria ENM
was stable in the perfusate at 37°C; no apparent agglomeration was observed from 1 to 230 minutes. The particle size
of the ceria ENMs was within ±1 SD after addition of the
ceria ENM to the perfusate (Figure 2). In this experiment,
the stability of the ceria ENM in the perfusate is crucial for
understanding how the ceria ENM interacts with capillary
cells and brain tissue.

Flow rate dependency
Comparison of uptake space (Qceria ENM) using 15 and 20 mL/
minute flow rates did not show a significant flow rate effect
on brain ceria ENM uptake in any of the eight brain regions
or the choroid plexus. Furthermore, there was no significant
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Figure 1 Ceria ENM morphology. (A) Ceria ENM imaged using TEM. The insert at the top right shows the crystallinity of the ceria ENM. (B) Volume-based particle size
distribution for ceria ENM of a representative batch of ceria aqueous dispersion.
Abbreviations: ENM, engineered nanomaterial; TEM, transmission electron microscopy.

difference in the vascular space with these two flow rates or
between the control and treated groups. However, the choroid
plexus showed a significantly higher vascular space than the
eight brain regions (Figure 3). The brain vascular space results
were similar to those we measured using [14C]-sucrose.28
A 20 mL/min flow rate was used for the rest of study.

Ceria ENM uptake
To investigate the 5 nm ceria brain entry rate, its uptake space
(Qceria ENM) was determined for each brain region for each of
the three ceria perfusate concentrations. Figure 4A shows that
the uptake space significantly decreased with the increase of

ceria ENM concentration in the perfusate. In the 30 µg/mL
group, there were no significant differences among the nine
regions. However, in the 100 and 500 µg/mL groups, choroid
plexus uptake space was significantly higher than in the eight
brain regions. In order to compare ceria ENM uptake among
the three concentrations, we calculated the mass amount
of ceria uptake into the brain as µg/g (Figure 4B). There
were no significant differences among the three treatment
concentrations. The mass amount of ceria in the choroid
plexus uptake space was significantly higher than in the eight
brain regions, and it was significantly higher in the 100 and
500 µg/mL groups than in the 30 µg/mL group. The average
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Figure 2 Ceria ENM hydrodynamic diameter in perfusate. Hydrodynamic diameter (intensity weighted average) of ceria ENM in the in situ perfusate, from 1 to 230 minutes
(1000 µg/mL at 37°C) after ceria was added to the perfusate.
Notes: Solid circles are DLS data; black solid line is the average of all the data. Dotted lines represent the average diameter ± 1 SD.
Abbreviations: ENM, engineered nanomaterial; DLS, dynamic light scattering; Dmean, diameter mean.
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Figure 3 Vascular space of the brain as measured by Gd-DTPA at 15 (n = 4) and 20 (n = 5) mL/minute flow rate in control rats and 20 (n = 10) mL/minute flow rate in
5 nm ceria-treated rats.
Note: *Significantly different from eight brain regions, P , 0.05.
Abbreviation: Gd-DTPA, gadolinium-diethylenetriamine pentaacetic acid.

mass amount of ceria per brain hemisphere (0.85 g, excluding
choroid plexus) was 4.2 ± 0.7 µg. To verify whether the
uptake space of ceria ENM rapidly saturates, ceria uptake
space was determined for 30 µg ceria ENM/mL for 20-, 60-,
and 120-second perfusion durations. There were significant
increases of uptake space to multiple brain regions from 20 to
60 seconds, but no differences between 60 and 120 seconds,
suggesting that the uptake space of this ceria ENM saturated
between 20 and 60 seconds (Figure 4C). The increased
uptake space of the 5 nm ceria ENM showed that the ceria
ENM either associated with capillary endothelial cells or
entered the brain. In the next step, ceria ENM distribution
between cerebral capillary cells and brain parenchyma was
determined.

Isolation of cerebral capillaries
Cerebral capillaries were isolated from brain parenchyma to
investigate the distribution of ceria ENM between these two
fractions. Less than 0.4% of the perfused ceria ENM dose was
associated with cerebral capillaries and brain parenchyma.
This separation revealed that a great majority of the ceria
ENM (99.4% ± 1.1% of the total ceria ENM in the capillaryrich fraction plus brain-rich fraction) was associated with
the capillary endothelial cells. Less than 0.003% of the ceria
ENM dose was associated with the brain-tissue-rich fraction
(Figure 5). These results suggest that most of the 4.2 ± 0.7 µg
ceria ENMs in the perfused brain hemisphere were associated
with the capillary endothelial cells, and very little ceria ENM
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passed through the endothelial cells into brain extracellular
fluid or brain cells.

Ceria ENM localization using LM and EM
Light and electron microscopy were used to confirm BBB
integrity and determine the localization of ceria ENM in the
endothelial cells and/or brain parenchyma. Light microscopy
examination of the choroid plexus revealed the presence
of a cuboidal epithelial cell layer surrounding a core of
capillaries, with some surrounding loose connective tissue.
There appeared to be no physical injury from exposure to
the high perfusate flow rate (Figure 6A). A capillary in the
mid-CA1 region of the hippocampus is shown in Figure 6B.
The pyramidal cells appear unaffected by in situ perfusion.
In the posterior pituitary, capillaries were not affected by the
high perfusate flow rate (Figure 6C).
At the ultrastructural level, the endothelial lining of the
choroid plexus appeared intact (Figure 7A). The adjacent
ependymal cell layer was lined by tightly adhering cells
with well-developed surface microvilli creating frond-like
processes projecting into the ventricles. Consistent with the
high ceria concentration in the choroid plexus, electron-dense
ceria ENM agglomerations were observed on the endothelial
lining (Figure 7A). Meanwhile, electron-dense nonagglomerated ceria ENM particles adhered to the endothelial lining in
the hippocampal vessels (Figure 7B) and the pituitary gland
vessels that lacked a BBB (Figure 7C). Ceria ENM associated with the surface of brain capillary endothelial cells.
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Figure 4 Ceria ENM uptake space at three concentrations and perfusion duration times. Effect of ceria ENM concentration and perfusion duration on its uptake. (A) Q uptake
space (mL/g) of a 5 nm ceria ENM in eight brain regions and the choroid plexus for three concentrations, at a flow rate of 20 mL/minute, and 120-second perfusion duration.
(B) Mass amount (µg/g) of 5 nm ceria ENM in eight brain regions and the choroid plexus after brain perfusion with three ceria concentrations, at a flow rate of 20 mL/minute
and perfusion duration of 120 seconds. (C) Q uptake space (mL/g) of 5 nm ceria ENM in eight brain regions and choroid plexus after 20-, 60-, and 120-second perfusion at
30 µg/mL, at a flow rate of 20 mL/minute.
Notes: (A) #Significantly different among three concentration groups, P , 0.05; *significantly different compared to the eight brain regions at the same concentration,
P , 0.05. (B) #Significantly different compared to 30 µg/mL concentration group; *significantly different compared to the eight brain regions, P , 0.05. (C) #Significantly
different between 20- and 60-second perfusion duration groups, P , 0.05.
Abbreviation: ENM, engineered nanomaterial.
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with the brain endothelial cells was a very rapid process that
saturated between 20 and 60 seconds using a flow rate of
20 mL/minute and ceria ENM concentration of 30 µl/mL.
Electron microscopy revealed that the ceria ENM associated
with the capillary luminal wall, and it was not seen inside
the brain capillary endothelial cells.
Prior to recent studies, how metal- or metal oxide-ENMs
interact with or cross the brain capillary endothelial cells was
poorly understood. One of the issues relevant to how nanomaterials interact with biological membranes is that “what
the cell sees” may not be the same as the ENM introduced
into the study preparation (eg, cells in culture, intact mammal
in this study). Several researchers have shown that ENMs
agglomerate in cell culture media.9,22 In blood, plasma proteins rapidly adsorb to nanoparticle surfaces to form a protein
corona that can change the physicochemical properties and
influence the fate of ENMs.20,36,37 It is difficult to interpret
some in vitro and in vivo nanoparticle studies, due to their
agglomeration in cell culture media and development of the
protein corona in blood. In our studies, we used a technique
that does not allow the nanoparticles to mix with blood. We
determined the size distribution and stability of our ceria
ENM in the perfusate from 1 to 230 minutes. The results did
not show agglomeration, which was supported by EM images
that did not show significant ceria ENM agglomeration in
the rat brain. This is the first report of ceria ENM interaction
with the BBB, in vivo, under conditions that control ENM
chemistry. This research helps us to understand citrate-coated
5 nm ceria brain capillary cell association, potential brain
entry, and redistribution. The in situ brain perfusion technique is a good experimental method by which to investigate
how physicochemical properties influence the interaction
of ENMs with, or their crossing of, the BBB in the absence
of major agglomeration and a protein corona. The research
helps us understand how certain physicochemical properties
influence the ability of ENMs to associate with or cross the
BBB for therapeutic application.
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Figure 5 Capillary depletion results. The percentage of the ceria ENM dose in the
capillary-rich fraction and brain-rich fraction for 100 µg/mL, at a flow rate of 20 mL/
minute, 120-second perfusion duration, followed by 20-second washout.
Abbreviation: ENM, engineered nanomaterial.

No ceria ENM was observed in any brain parenchyma, consistent with our capillary depletion results. The ultrastructural
data lend support to the calculation that 2.4% ± 0.4% of the
luminal surface area of the capillary endothelial cells would
be occupied by the 4.2 ± 0.7 µg ceria ENM per hemisphere
measured in our uptake study.

Discussion
The results demonstrate that this ceria ENM did not influence BBB integrity. Perfusate flow rate and ceria ENM
concentration did not influence ceria ENM uptake into
brain parenchyma, providing evidence of a non-diffusion
mechanism. The uptake space of the 5 nm ceria ENM did
increase, compared to the vascular space, leading to the
conclusion that the 5 nm ceria ENM either associated with
capillary endothelial cells or entered the brain. The capillary depletion method showed that most of the ceria ENM
associated with the capillary cells. Association of the ceria

Figure 6 The capillaries in the (A) choroid plexus, (B) hippocampus (mid-CA1 region), and (C) pituitary were not affected by the high perfusate flow rate.
Note: Rats were perfused with 100 µg ceria ENM/mL, at a flow rate of 20 mL/minute, and perfusion duration of 120 seconds.
Abbreviation: ENM, engineered nanomaterial.
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Figure 7 (A) A capillary with intact endothelial lining in the choroid plexus containing two ceria ENM agglomerates (arrows). (B) A vessel in the hippocampus and
(C) a vessel from the pituitary gland associated with fine ceria ENM (arrows).
Note: Rats were perfused with 100 µg ceria ENM/mL, at a flow rate of 20 mL/minute, and perfusion duration of 120 seconds.
Abbreviation: ENM, engineered nanomaterial.

Our results showed that most of the ceria ENMs were
associated with brain capillary cells rather than brain cells.
Several studies reported that metal- and metal oxide-ENMs
cross the BBB.15,16,38,39 Without separating brain capillary cells
from brain cells, it is very possible that the ENMs in those
studies were associated with endothelial cells rather than
entering brain parenchyma. For example, based on ICP-MS
results of brain metal content, bovine serum albumin-coated
silver-ENM was found in the brain, compared with the control. Signs of silver-induced brain damage were observed;
however, EM did not reveal silver-ENMs in the brain.40 It
is possible that the silver-ENMs associated with the BBB
and released silver ions to produce the toxicity, rather than
being an effect of silver-ENMs. A previous study using the
in situ brain perfusion method reported that polymer-based
nanoparticles entered the central nervous system within
60 seconds, without influencing BBB integrity. However,
the researchers did not separate the capillary cells from the
brain parenchyma. They showed an uptake space similar to
results we obtained at 20 and 60 seconds. Capillary association also may contribute to their brain uptake space.41 Our
previous studies showed only 0.02% of a 5 nm ceria dose
in the brain 1 hour after IV infusion. However, we did not
observe any 5 nm ceria ENM in the brain tissue.19 In light of
the results in this paper, the 0.02% ceria in the brain may be
ceria ENM in blood and associated with capillary cells. In
this study, brain association (0.383% of the ceria ENM dose)
using in situ perfusion is 19 times higher than our previous
report of ceria ENM in the brain (0.02% of the ceria dose)
1 hour after IV infusion. The different timelines (in the prior
study, brain samples were obtained 1 hour after completion
of ceria infusion; in the present study, the samples were
obtained immediately after completion of ceria perfusion)
and routes (IV versus intra-carotid artery) contributed to the
differences in brain ceria ENM. In the present study using
in situ brain perfusion, ceria ENM did not mix with blood
and avoided first-pass clearance. After IV administration,

International Journal of Nanomedicine 2012:7

ceria ENM agglomerated in the blood, and protein corona
formation changed its physicochemical properties, resulting
in rapid clearance by the mononuclear phagocyte system.21,26
Ceria ENM may associate with brain capillary cells during a
120-second perfusion and dissociate later. The above reasons
may explain the high brain capillary/ceria ENM association,
compared with our previous IV infusion study.
Our EM results showed that most of the ceria ENM is
on the luminal surface of brain capillary cells rather than
inside these cells. Brain capillary cell association with
this negatively charged ceria ENM is in agreement with a
previous kinetic study that reported a negatively charged
nanoparticle associated with the cell surface, within seconds,
by Langmuir adsorption through electrostatic interaction.42
After surface adsorption, the next step may be dissociation
and redistribution or cell internalization. The time course of
cell internalization of metal oxide nanoparticles is still under
investigation. Anionic iron oxide-ENMs attached onto the cell
membrane of HeLa cells immediately after ENM introduction
to the cells. Early endocytic-coated vesicles were observed at
10 minutes.42 Most of the literature we are aware of showed
cell line- and material-dependent ENM internalization half
lives of more than a few minutes in vitro and in vivo.42–46 In
three different cancer cells, 14, 50, and 74 nm gold nanoparticles had uptake half-lives of more than 1 hour.43 Flux
of cationic arginine–vasopressin nanoparticles across the
BBB started at 15 minutes through absorptive-mediated
endocytosis in mice.45 Because of the nature of the in situ
perfusion technique, perfusion duration in the present study
was not greater than 120 seconds.34 More research is needed
to understand what happens after the ceria ENMs interact
with brain capillary cells. However, no matter what does
happen, it is very important to know the rate and extent of
cell surface adsorption, as it is the initial step for ENM cell
uptake and potential redistribution back into the blood.
In this study, capillary depletion results showed ceria
ENM associated with brain endothelial cells. Electron
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microscopy failed to find any 5 nm ceria in brain parenchyma;
however, nonagglomerated ceria ENM was observed to
associate with the luminal wall of brain capillary endothelial
cells. Assuming that all of the ceria associated with the capillary surface without any agglomeration, and based on the
mass of ceria ENM we observed in the rat brain after arterial
ceria ENM perfusion, our calculation showed that 2.4% ± 0.4%
of the brain capillary surface area might be covered by the
ceria ENM. We think that the 4.2 ± 0.7 µg of ceria ENM per
brain hemisphere seen in the present study might contribute
to ceria ENM redistribution or sustained release back into
the blood. Ceria ENM dissociation from the brain capillary
luminal wall over time may provide an explanation for findings in our pharmacokinetic study, wherein the circulating
blood level of two sizes of ceria ENMs increased from 2 to
4 hours after completion of their IV infusion, which cannot
be explained using conventional pharmacokinetics.26 A similar increase of ENM in blood within the first 2 hours after
its IV administration has been reported for quantum dots;
however, explanation of the increase was not discussed in
these reports.47,48 ENMs that associate with, and subsequently
disassociate from, the vascular wall might provide an
explanation. Another study showed that 100–200 nm ceria
ENMs (primary size, 3–5 nm) were observed on the luminal
surface of mouse tail veins 30 days post-IV injection.49 It is
not known if these agglomerated ceria nanoparticles were
from original association with the blood vessel or from redistribution over time. In general, our results showed that ENMs
can associate with capillary cells, which may contribute to
nanoparticle redistribution back into the blood.
This is the first study to report that a ceria ENM has a
higher concentration in the choroid plexus compared with
brain regions. Our vascular space results, measured by GdDTPA, showed that the choroid plexus has a larger vascular
space than brain tissues. The choroid plexus showed a significantly higher uptake space compared with brain regions
in the 100 and 500 µg/mL concentration groups, but not in
the 30 µg/mL group. The choroid plexus uptake space did
not change between the 100 and 500 µg/mL groups. Little
is known about how metal oxide nanoparticles interact with
the choroid plexus. The choroid plexus has larger surface
area per mass, a leakier epithelial barrier, and different
tight junction proteins and transport protein expression
compared to cerebral endothelium.50,51 The fundamental
differences between the choroidal epithelium and the cerebral endothelium may influence the ceria ENM association
sites and determine the ceria ENM saturation concentration.
Ceria agglomerates (Figure 7) were observed in the choroid
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plexus, compared to primary fine ceria ENM on the surface
of the brain endothelial cells, providing evidence that ceria
ENM may associate with the choroid plexus differently than
the BBB, leading to higher concentrations in the choroid
plexus. Previous research showed that the choroid plexus
sequesters metal ions rapidly, and that their concentrations
were more than ten times higher than other brain regions.28,52
Some polymer nanoparticles showed similar results as the
present study. Poly (d,l-lactide-co-glycolide) nanoparticles
showed a high concentration in the choroid plexus.53 The
choroid plexus is considered a potential region to retain
nanoparticles,54 and a pathway to enter the central nervous system.51,55 Our results provide the first evidence that
ceria ENMs interact significantly with the choroid plexus;
this information is very important for toxicity concerns and
therapeutic applications.

Conclusion
Brain uptake of a 5 nm ceria ENM was flow rate- and
perfusion concentration-independent, showing that
diffusion was not mediating its association with brain tissue.
The ceria ENM concentration was significantly higher in the
choroid plexus than in eight brain regions. Brain ceria ENM
association was a very rapid process that reached saturation
between 20 and 60 seconds. The capillary depletion method
showed that the ceria ENM was predominantly associated with the brain capillary cells rather than with brain
parenchyma. Furthermore, EM showed that most of the
ceria ENM associated with the luminal surface of brain
endothelial cells, rather than entering the cells. This research
provides the first data on the kinetics of ceria ENM interaction with the BBB and choroid plexus. Ceria ENM capillary
cell surface association also provides a site from which it
can dissociate, redistribute, or enter the capillary cells.
This information will be important for the design of ceria
ENMs as a therapeutic agent, as well as for a comprehensive
toxicology assessment.
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Materials and methods
Materials
The chemicals used to prepare the ceria engineered
nanomaterials (ENMs) have been described.1 Cerium chloride heptahydrate (#228931, 99.9% metal basis; SigmaAldrich, St Louis, MO), ammonium hydroxide (Thermo
Fisher Scientific, Waltham, MA; #3256, ACS, 28%–30%),
deionized ultra filtered water (Thermo Fisher Scientific;
#W2-20), and citric acid monohydrate (EMD Millipore,
Billerica, MA; #CX1725-1, GR ACS) were used without
further purification. All other chemicals were purchased from
Sigma-Aldrich unless otherwise noted.

Ceria ENM synthesis
Synthesis of the 5 nm ceria ENM was described.2 It was
synthesized using a hydrothermal method3 that produces
monodisperse nanoparticles directly in the reactor. Typically,
a 20 mL aqueous mixture of 0.5 M (0.01 mol) cerium chloride
and 0.5 M (0.01 mol) citric acid was added to 20 mL of 3 M
ammonium hydroxide. The latter was in excess of what was
needed for complete reaction of the cerium chloride to cerium
hydroxide. After stirring for 24 hours at 50°C, the solution
was transferred to a Teflon-lined, stainless steel bomb, and
heated at 80°C for 24 hours to complete the reaction. The
ceria ENMs were citrate coated (capped) to improve their
dispersity in water to stabilize dispersion through electrostatic
repulsion and prevent the agglomeration seen with uncoated
ceria that occurs in high ionic strength solutions, such as
blood.4–6 Citrate was selected because: it is a commonly used
surface coating agent for ENMs to inhibit agglomeration
(eg, National Institute of Standards of Technology reference materials 8011, 8012, and 8013 [NIST, Gaithersburg,
MD]); it is a component of blood (present at ~100 µM in
humans); it might coat bare ENMs circulating in blood; it
has been shown to have no effect on erythrocyte response
to silver-ENMs; and citrate-coated ENMs interact strongly
with proteins, resulting in the rapid opsonization that occurs
when ENMs enter blood.7–9

Ceria ENM characterization
The physicochemical properties of the ceria ENMs were
determined in our laboratories. Most of the methods have
been reported.1 Primary particle size distributions were
determined by transmission electron microscopy (TEM)
and scanning transmission electron microscopy (200-keV
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field emission analytical transmission electron microscope,
JEM-2010F; JEOL, Tokyo, Japan). From the individual
primary particle sizes measured from TEM images, number
frequency cumulative distributions were constructed. These
cumulative distributions were best described by log-normal
distribution models, characterized by a sample mean and its
standard deviation. All of these data sets were well described
by a single monomodal distribution; that is, one continuous
distribution was observed, and no significant secondary or
tertiary peaks were noted. The reported average diameter
of each sample was Dave = exp (µ), where µ is the mean of
the log-normal probability distribution and the reported
standard deviation is the value from the fit of the log-normal
distribution to the data. For each sample, number-based
differential frequency distributions were constructed using
the model coefficients. The particle size distributions for
each batch of as-synthesized ceria aqueous dispersion were
determined using dynamic light scattering (DLS; 90Plus
N anoParticle Size Distribution Analyzer; Brookhaven
Instruments Corporation, Holtsville, NY). Zeta potential of the ceria dispersion as infused into the rat was
estimated from electrophoretic mobility measurements,
using a Zetasizer nanoZS with a typical ceria concentration ~0.02 wt% (Malvern Instruments, Worcestershire, UK). Because the particles had hydrodynamic
diameters < 200 nm, the Hückel approximation was used
to calculate zeta potential from electrophoretic mobility. The surface area of the dried powder was determined
using a Brunauer–Emmett–Teller surface area analyzer
(Micromeritics Instrument Corporation, Norcross, GA).
Thermogravimetric analysis (TGA7 Analyzer; PerkinElmer,
Waltham, MA) was then performed to investigate the
weight loss of citrate-coated ceria nanoparticles (NPs)
over a 150°C–300°C temperature range, during which
decomposition of citric acid occurs. The extent of citrate
surface coating was estimated based on the assumption that
all the ceria NPs were spherical and of uniform size.
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